Burimamide
Burimamide is a histamine antagonist and the first H2 receptor antagonist to be discovered. It was developed by Sir James Black and his team at Smith, Kline & French in the 1970s. Burimamide is a specific antagonist of the histamine H2 receptor, which is found in the stomach lining and is responsible for stimulating gastric acid secretion.
History[edit | edit source]
Burimamide was the first H2 receptor antagonist to be discovered. It was developed by Sir James Black and his team at Smith, Kline & French in the 1970s. The discovery of burimamide led to the development of cimetidine, the first H2 receptor antagonist to be marketed.
Pharmacology[edit | edit source]
Burimamide is a specific antagonist of the histamine H2 receptor. This receptor is found in the stomach lining and is responsible for stimulating gastric acid secretion. By blocking this receptor, burimamide reduces the production of stomach acid.
Clinical use[edit | edit source]
While burimamide itself is not used clinically, its discovery led to the development of cimetidine, which is used to treat conditions such as peptic ulcers and gastroesophageal reflux disease (GERD).
See also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
